Dr Bruce Sherman Explores the Role of Equitable Health Benefit Design in the US
"From a health benefit standpoint, specifically, the employees have to be able to access care, they have to be able to afford the care that they are going to receive, and the benefits also have to be relevant to employees," Bruce Sherman, MD explains.
Patients With Multiple Myeloma Lack Awareness of CAR T-Cell Therapy, Research Says
The results indicated that a substantial proportion of patients, particularly in rural, less educated, and elderly demographics, are insufficiently informed about novel MM treatments, including chimeric antigen receptor (CAR) T-cell therapies and bispecific antibody alternatives.
California Aims for Equity by Redefining Cancer Care
Authors highlight key aspects of the California Cancer Care Equity Act, including its focus on Medi-Cal beneficiaries, the requirement for managed care plans to contract with specialized cancer centers, and the definition of complex cancers.
Research Reveals the Role of Structural Racism in Lung Cancer Risk
Spanning 22 studies, the analysis illuminated housing disparities, occupational hazards, unequal health care access, economic inequality, and discriminatory industry practices and how they collectively contribute to heightened lung cancer risks.
Obesity Advocates Challenge FDA Over Drug Approval Process Disparities
The Obesity Action Coalition and other organizations are urging the FDA to address critical gaps in drug testing, emphasizing the need for specific testing in individuals with obesity to ensure safety and efficacy, as current practices expose this population to unnecessary risks.
Health Equity and Access Weekly Roundup: December 2, 2023
The Center on Health Equity and Access highlights the most recent updates in the realm of health equity, including news, research findings, and initiatives focused on mitigating health care disparities and enhancing overall access to quality care.
Dr Alvaro Pascual-Leone Discusses Disparities in Alzheimer Disease Research
Alvaro Pascual-Leone, MD, PhD, addresses the role of the gene variant APOE4 in Alzheimer disease and dementia, noting its influence on risk factors and the significance of early diagnosis for effective intervention across all racial groups.
Study Validates Smartphone Analysis for Predicting Obstructive Sleep Apnea
Findings show breathing sounds recorded by smartphones during sleep at home can reliably identify obstructive sleep apnea, presenting an innovative and accessible alternative to traditional in-laboratory polysomnography.
Dr Jeffrey Sippel: Medicare Advantage NIV Denials Take Time From Patients With ALS
Jeffrey Sippel, MD, MPH, addresses the increasing denial of insurance claims for non-invasive ventilators (NIV) in Medicare Advantage plans, particularly impacting ALS patients, emphasizing the time crunch on patients, and criticizing the financial focus over patients' well-being.
Dr Jeffrey Sippel: The Impact of Insurance Denials for Patients With ALS
Due to the frequent rejection of claims for noninvasive ventilators by Medicare Advantage plans, individuals with amyotrophic lateral sclerosis (ALS) are experiencing disproportionately high rates of hospital admissions.
Study Reveals Racial Disparities in Immune Tolerance Induction Treatment for Hemophilia
New research highlights racial disparities in hemophilia care, revealing that Black and Hispanic patients are significantly less likely to receive immune tolerance induction treatment compared with White patients, even after considering clinical factors.
A Comprehensive Approach to Fourth-Trimester Care Aims to Overcome Newborn Health Disparities
Care in the fourth-trimester, when the birth has taken place and the mother and baby return home, is crucial for the well-being of the mother or the birthing person, Takiyah Durham, MBA, explains in an interview.
Addressing Racial Disparities in Health Care Expenditures: The Impact of Racial and Economic Equity
“Our findings further reinforce that place is important and that the social, economic, and health care equity context is key to minimizing health care expenditure disparities for Black adults in the US," investigators explain.
Etranacogene Dezaparvovec Gene Therapy Outperforms FIX Products in Hemophilia B
The findings from a recent study unveiled notable distinctions in bleeding rates between etranacogene dezaparvovec and the standard prophylactic factor IX (FIX) products among individuals diagnosed with hemophilia B.
Study Identifies Core Instruments for Monitoring Physical Function in Hemophilia
The study identified practical instruments for monitoring physical function in people with hemophilia by pinpointing 11 potential markers and establishing performance-based tests for 5 of these activities.
Damoctocog Alfa Pegol Demonstrates Safety and Efficacy in Hemophilia A
While clinical trials offer controlled data, real-world studies like HEM-POWR bridge gaps, confirming damoctocog alfa pegol’s effectiveness and tolerance, establishing it as a valuable hemophilia A treatment option.